We are live on
!
Find out more
IMDX
Insight Molecular Diagnostics
IMDX
IMDX
27 hedge funds and large institutions have $54.1M invested in Insight Molecular Diagnostics in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
10% less funds holding
Funds holding: 30 → 27 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
27
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.62M | |
| 2 | +$157K | |
| 3 | +$115K | |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$80.2K |
| 5 |
State Street
Boston,
Massachusetts
|
+$62.9K |
Top Sellers
| 1 | -$99.4K | |
| 2 | -$53.9K | |
| 3 | -$35.7K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$35.6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10.8K |